99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
FDA warns of counterfeit ozempic

FDA warns of counterfeit ozempic

by Dennis ThompsonThe U.S. Food and Drug Administration has uncovered counterfeit Ozempic shots in the legitimate U.S. drug supply chain, and is warning patients to be on their guard.The FDA said Thur

FDA warns of counterfeit ozempic

by Dennis ThompsonThe U.S. Food and Drug Administration has uncovered counterfeit Ozempic shots in the legitimate U.S. drug supply chain, and is warning patients to be on their guard.The FDA said Thur
ASH: Daratumumab beneficial for patients with multiple myeloma

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio

ASH: Daratumumab beneficial for patients with multiple myeloma

by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Researchers identify molecular link between gut bacteria and excitatory brain signaling in C. elegans

Researchers identify molecular link between gut bacteria and excitatory brain signaling in C. elegans

by Jim Fessenden, UMass Chan Medical SchoolB12produced by gut bacteria suppresses the hyperactive behavior of unc-2(gof) mutants. Credit:Nature Cell Biology(2024). DOI: 10.1038/s4155

Researchers identify molecular link between gut bacteria and excitatory brain signaling in C. elegans

by Jim Fessenden, UMass Chan Medical SchoolB12produced by gut bacteria suppresses the hyperactive behavior of unc-2(gof) mutants. Credit:Nature Cell Biology(2024). DOI: 10.1038/s4155
Simnotrelvir shortens time to resolution of symptoms in COVID-19

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in
The long—and strange—history of testing menstrual blood for health conditions

The long—and strange—history of testing menstrual blood for health conditions

by Helen King,The ConversationCredit: public domainThere's good news for anyone who menstruates and doesn't like the needles involved in blood testing. In January 2024, the biotechnology

The long—and strange—history of testing menstrual blood for health conditions

by Helen King,The ConversationCredit: public domainThere's good news for anyone who menstruates and doesn't like the needles involved in blood testing. In January 2024, the biotechnology
Researchers help design easy-to-open, child-resistant medicine bottle

Researchers help design easy-to-open, child-resistant medicine bottle

by Abby Robinson,Georgia Institute of TechnologyEquipment used by Georgia Tech Research Institute (GTRI) product design researchers measures the forces required to open prescription medicine con

Researchers help design easy-to-open, child-resistant medicine bottle

by Abby Robinson,Georgia Institute of TechnologyEquipment used by Georgia Tech Research Institute (GTRI) product design researchers measures the forces required to open prescription medicine con
Poor trial results may prompt maker to pull ALS drug from market

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
A new weapon against the super-tough C diff bacteria tested in phase-one human trial

A new weapon against the super-tough C diff bacteria tested in phase-one human trial

by Laurie Fickman,University of HoustonFecal drug concentrations of omadacycline and vancomycin. Credit:The Journal of Infectious Diseases(2023). DOI: 10.1093/infdis/jiad537In a phas

A new weapon against the super-tough C diff bacteria tested in phase-one human trial

by Laurie Fickman,University of HoustonFecal drug concentrations of omadacycline and vancomycin. Credit:The Journal of Infectious Diseases(2023). DOI: 10.1093/infdis/jiad537In a phas
Gene therapy gets a turbo boost from researchers

Gene therapy gets a turbo boost from researchers

byUniversity of Hawaii at ManoaGraphical abstract. Credit:Nucleic Acids Research(2024). DOI: 10.1093/nar/gkae534For decades, scientists have dreamed of a future where genetic disease

Gene therapy gets a turbo boost from researchers

byUniversity of Hawaii at ManoaGraphical abstract. Credit:Nucleic Acids Research(2024). DOI: 10.1093/nar/gkae534For decades, scientists have dreamed of a future where genetic disease
Study finds growing use of hemp-derived alternative cannabis products containing CBD, Delta-8-THC, CBG, CBN

Study finds growing use of hemp-derived alternative cannabis products containing CBD, Delta-8-THC, CBG, CBN

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainCannabis use for medicinal or recreational purposes is now permitted is most states in the U.S. Many of the products sold in dispensaries

Study finds growing use of hemp-derived alternative cannabis products containing CBD, Delta-8-THC, CBG, CBN

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainCannabis use for medicinal or recreational purposes is now permitted is most states in the U.S. Many of the products sold in dispensaries